Intermittent and episode-driven use of pranlukast to reduce the frequency of wheezing in atopic children: a randomized, double-blind, placebo-controlled trial.

导出 LinkOut

翻译打印收藏纠错

作者： Motohiro,Ebisawa ^[1] ; Akihiko,Terada ^[2] ; Kazuki,Sato ^[3] ; Fumitake,Kurosaka ^[4] ; Naomi,Kondo ^[5] ; Chizuko,Sugizaki ^[1] ; Akihiro,Morikawa ^[6] ; Sankei,Nishima ^[7] ; Mitsuyoshi,Urashima ^[8]

作者单位： Department of Allergy, Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan. ^[1] Department of Pediatrics, Daido Hospital, Nagoya, Japan. ^[2] Department of Pediatrics, National Shimoshizu Hospital, Yotsukaido, Japan. ^[3] Kurosaka Pediatrics and Allergy Clinic, Himji, Japan. ^[4] Gifu University Graduate School of Medicine, Gifu, Japan. ^[5] Gunma University & Kitakanto Allergy Institute, Maebashi, Japan. ^[6] Allergy division, Fukuoka National Hospital, Fukuoka, Japan. ^[7] Division of Molecular Epidemiology, Jikei University School of Medicine, Nishi-shimbashi 3-25-8, Minato-ku, Tokyo 105-8461 Japan. ^[8]

关键词 Asthma exacerbations Children Japan Leukotriene receptor antagonist Pranlukast

DOI 10.1186/s40413-015-0062-3

PMID 25866598

发布时间 2023-04-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交